Abstract
An 82-year-old man with a history of endovascular repair for ruptured abdominal aortic aneurysm 6 years ago presented with a type II endoleak and enlarging sac. He had successful transabdominal direct sac puncture embolization but developed fever 2 days postoperatively. Contrast-enhanced computed tomography showed a rim-enhancing collection, and sac aspiration was positive for enteric organisms, confirming endograft infection. The patient underwent graft explantation and neoaortic reconstruction using superficial femoral veins. Three months postoperatively, computed tomography showed complete resolution of fluid collection and no signs of graft infection. This report illustrates direct puncture embolization complicated by endograft infection from enteric bacteria.
Keywords: Abdominal aortic aneurysm, Endovascular aneurysm repair, Graft infection, Endoleak embolization, Aortic reconstruction
Graft infection after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm is a serious complication with an incidence of 0.6% and mortality rate of 45.7%.1 Most studies of graft infection have been performed on patients receiving open rather than endovascular repair.2, 3, 4 Furthermore, there are few reports of endograft infection after endoleak embolization.5 Given the lack of guidelines on managing this life-threatening condition, we present a case of EVAR graft infection after direct sac puncture embolization for type II endoleak that was successfully treated with neoaortic reconstruction using superficial femoral veins. The patient's consent was received for this report.
Case report
An 82-year-old man with a history of ruptured abdominal aortic aneurysm treated with EVAR 6 years ago presented to a community hospital with 4 days of right flank pain. Initial EVAR was performed with a Cook bifurcated endograft (Cook Medical, Bloomington, Ind) and intraoperative Palmaz stent (Cordis, Bridgewater, NJ) for type I endoleak. The patient had a history of type II endoleak treated with iliolumbar embolization 5 years ago and chronic kidney disease secondary to acute kidney injury after ruptured EVAR with a baseline creatinine concentration of 150 μmol/L.
Contrast-enhanced computed tomography (CT) showed a type II endoleak and 9.7-cm sac (Fig 1, A), which had enlarged by 1.9 cm since his last CT scan. A diagnosis of symptomatic aneurysm sac expansion secondary to type II endoleak was made. The patient was transferred to our academic vascular center for direct sac puncture embolization. Under ultrasound and CT fluoroscopic guidance, the aneurysm sac was punctured transabdominally with a trocar needle. Intraoperative angiography confirmed a type II endoleak originating from the lumbar arteries (Fig 1, B). Embolization using lipiodol and n-cyanoacrylate glue was completed with no obvious complications. Prophylactic antibiotics including cefazolin and metronidazole were administered.
Fig 1.

Type II endoleak demonstrated by (A) contrast-enhanced computed tomography (CT) scan and (B) angiography (originating from lumbar arteries).
He was transferred back to his community hospital but subsequently developed fever. Findings on noncontrast-enhanced CT were suggestive of graft infection. He was started on empirical broad-spectrum antibiotics and transferred back to our center for further investigation. On arrival, the patient was febrile but hemodynamically stable. His blood cultures were positive for Escherichia coli, and contrast-enhanced CT showed a rim-enhancing collection, psoas abscess, and locules of gas within the sac (Fig 2). This was consistent with endograft infection secondary to transabdominal embolization.
Fig 2.

Aortic endograft infection on contrast-enhanced computed tomography (CT) scan demonstrated by rim-enhancing collection, psoas abscess, and locules of gas within the sac.
Under CT fluoroscopic guidance, a drainage catheter was placed in the psoas abscess through a translumbar approach; 5 mL of fluid was aspirated, and the culture was positive for E. coli and other enteric bacteria including Bacteroides thetaiotaomicron, Parabacteroides distasonis, and Eggerthella lenta. Vein mapping showed that his femoropopliteal veins were patent, and echocardiography was negative for inducible ischemia. He was consented for endograft explantation and neoaortic reconstruction using bilateral superficial femoral veins.
From each of the superficial femoral veins, 15 cm was harvested. The proximal ends were spliced together to create a bifurcated vein graft. A midline laparotomy was performed, and the retroperitoneum was opened. Purulent fluid with a feculent smell and dense adhesions were observed. No enterotomy was identified on full bowel examination, consistent with needle puncture of the bowel rather than fistula.
An aortic clamp site was identified just above the left renal artery. After heparinization, the aneurysm sac was opened and purulent material was washed out. We dissected out the endograft and retrieved the Palmaz stent without difficulty. An aortobi-iliac repair was performed using the neoaorta. All infected material was débrided from the aortic sac and sent for culture.
After adequate hemostasis, the aortic sac was sutured over the vein graft, and the retroperitoneum was closed over the aorta. The laparotomy was closed, and the patient was transferred to the cardiovascular intensive care unit. Culture of the operative specimen was positive for B. thetaiotaomicron and P. distasonis, and the patient continued on intravenous fluconazole and meropenem.
A CT scan on postoperative day 7 showed a patent graft with no signs of ongoing infection. His recovery was complicated by delirium and fever secondary to pneumonia. On postoperative day 19, contrast-enhanced CT scan showed a sac size of 5.4 cm with minor wall enhancement, and no free gas was detected. The patient was discharged with graduated compression stockings when his delirium and pneumonia resolved.
One month later, he was seen for follow-up and resumed daily activities. His incisions were healed and pulses were palpable. His intravenous antibiotics were transitioned to oral amoxicillin-clavulanic acid for long-term infection suppression. Three months postoperatively, CT showed complete resolution of the fluid collection and no signs of ongoing graft infection (Fig 3). The patient is alive 18 months postoperatively with no issues related to his aortic reconstruction.
Fig 3.

Noncontrast-enhanced computed tomography (CT) scan demonstrating no signs of endograft infection 3 months postoperatively.
Discussion
Graft infection is a rare complication after EVAR, and no guidelines exist for managing this serious condition. The only other published case of endograft infection after direct puncture embolization for type II endoleak was reported by Harlock et al.6 However, the authors used a translumbar approach and the responsible organism was Propionibacterium acnes, a skin rather than an enteric bacterium. Because transabdominal puncture involves accessing the aorta through the abdomen, there is risk of inadvertent bowel injury and seeding of the endograft with enteric organisms.7 Our report illustrates the importance of querying graft infection in EVAR patients who develop fever after transabdominal embolization.
Transarterial and direct puncture techniques demonstrate similar efficacy in treating type II endoleak and preventing sac expansion.8, 9 In this case, we performed transabdominal direct puncture embolization because the patient presented again with type II endoleak after transarterial embolization and his endoleak was anatomically suitable for a transabdominal approach. Our institution is experienced with transabdominal embolizations, having performed 33 for type II endoleak between 2011 and 2016 with a technical success rate of 97%.10
The benefits of transabdominal embolization over a translumbar technique include better toleration of surgery with supine positioning and easier cannulation of lumbar artery origins.10 A transcaval approach may have lowered the probability of bowel injury, but it presents unique risks, including inadvertent intracaval embolization and aortocaval fistula.11 Direct repair with minilaparotomy is a more invasive approach for patients with persistent type II endoleak who have failed to respond to other embolization methods.12 This technique may be considered if the patient presents again with endoleak in the future.
Endograft infection can be managed medically or surgically. Because of high mortality rates, conservative management with antibiotics is reserved for patients who cannot tolerate surgery.13 Surgical management of aortic graft infection generally consists of graft explantation, débridement of infected tissue, and aortic revascularization. Traditionally, extra-anatomic bypass has been the standard of care,14 but recent evidence demonstrates that in situ reconstruction provides improved mortality, amputation, and long-term patency rates.15
Prosthetic, autogenous, and cryopreserved grafts are available for in situ reconstruction.16 Autogenous aortic reconstruction using the femoral-popliteal vein, first described by Clagett et al,17 provides better long-term patency, reinfection, and mortality rates than other methods.18
Applying neoaortic reconstruction using superficial femoral veins to our patient allowed complete resolution of endograft infection and recovery of quality of life within 3 months. Smeds et al7 published a case series of 206 patients demonstrating similar feasibility of this technique for managing endograft infection.
Conclusions
Seeding of the aneurysm sac with enteric organisms is a rare complication after transabdominal direct sac puncture embolization of post-EVAR type II endoleak. Neoaortic reconstruction using autogenous superficial femoral veins is a feasible treatment option for this complication.
Footnotes
J.B. was funded from the Bill and Vicky Blair Foundation as a Blair Early Career Professor in Vascular Surgery.
Author conflict of interest: none.
The editors and reviewers of this article have no relevant financial relationships to disclose per the Journal policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
References
- 1.Argyriou C., Georgiadis G.S., Lazarides M.K., Georgakarakos E., Antoniou G.A. Endograft infection after endovascular abdominal aortic aneurysm repair: a systematic review and meta-analysis. J Endovasc Ther. 2017;24:688–697. doi: 10.1177/1526602817722018. [DOI] [PubMed] [Google Scholar]
- 2.Ehsan O., Gibbons C.P. A 10-year experience of using femoro-popliteal vein for re-vascularisation in graft and arterial infections. Eur J Vasc Endovasc Surg. 2009;38:172–179. doi: 10.1016/j.ejvs.2009.03.009. [DOI] [PubMed] [Google Scholar]
- 3.Daenens K., Fourneau I., Nevelsteen A. Ten-year experience in autogenous reconstruction with the femoral vein in the treatment of aortofemoral prosthetic infection. Eur J Vasc Endovasc Surg. 2003;25:240–245. doi: 10.1053/ejvs.2002.1835. [DOI] [PubMed] [Google Scholar]
- 4.van Zitteren M., van der Steenhoven T.J., Burger D.H., van Berge Henegouwen D.P., Heyligers J.M., Vriens P.W. Spiral vein reconstruction of the infected abdominal aorta using the greater saphenous vein: preliminary results of the Tilburg experience. Eur J Vasc Endovasc Surg. 2011;41:637–646. doi: 10.1016/j.ejvs.2011.01.020. [DOI] [PubMed] [Google Scholar]
- 5.Etienne H., Touma J., Becquemin J.P. Unusual acute onset of abdominal aortic endograft infection by Propionibacterium acnes after coil embolization for type II endoleak. Ann Vasc Surg. 2016;35:204.e9–204.e11. doi: 10.1016/j.avsg.2016.01.036. [DOI] [PubMed] [Google Scholar]
- 6.Harlock J.A., Qadura M., Lee G., Szalay D.A. Infected aortic stent graft with Propionibacterium acnes. Vasc Endovascular Surg. 2013;47:394–396. doi: 10.1177/1538574413487262. [DOI] [PubMed] [Google Scholar]
- 7.Smeds M.R., Duncan A.A., Harlander-Locke M.P., Lawrence P.F., Lyden S., Fatima J. Treatment and outcomes of aortic endograft infection. J Vasc Surg. 2016;63:332–340. doi: 10.1016/j.jvs.2015.08.113. [DOI] [PubMed] [Google Scholar]
- 8.Yang R.Y., Tan K.T., Beecroft J.R., Rajan D.K., Jaskolka J.D. Direct sac puncture versus transarterial embolization of type II endoleaks: an evaluation and comparison of outcomes. Vascular. 2017;25:227–233. doi: 10.1177/1708538116663992. [DOI] [PubMed] [Google Scholar]
- 9.Stavropoulos S.W., Park J., Fairman R., Carpenter J. Type 2 endoleak embolization comparison: translumbar embolization versus modified transarterial embolization. J Vasc Interv Radiol. 2009;20:1299–1302. doi: 10.1016/j.jvir.2009.07.003. [DOI] [PubMed] [Google Scholar]
- 10.Zener R., Oreopoulos G., Beecroft R., Rajan D.K., Jaskolka J., Tan K.T. Transabdominal direct sac puncture embolization of type II endoleaks after endovascular abdominal aortic aneurysm repair. J Vasc Interv Radiol. 2018;29:1167–1173. doi: 10.1016/j.jvir.2018.04.002. [DOI] [PubMed] [Google Scholar]
- 11.Scali S.T., Vlada A., Chang C.K., Beck A.W. Transcaval embolization as an alternative technique for the treatment of type II endoleak after endovascular aortic aneurysm repair. J Vasc Surg. 2013;57:869–874. doi: 10.1016/j.jvs.2012.09.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ferrari M., Sardella S.G., Berchiolli R., Adami D., Vignali C., Napoli V. Surgical treatment of persistent type 2 endoleaks, with increase of the aneurysm sac: indications and technical notes. Eur J Vasc Endovasc Surg. 2005;29:43–46. doi: 10.1016/j.ejvs.2004.10.008. [DOI] [PubMed] [Google Scholar]
- 13.Lyons O.T., Patel A.S., Saha P., Clough R.E., Price N., Taylor P.R. A 14-year experience with aortic endograft infection: management and results. Eur J Vasc Endovasc Surg. 2013;46:306–313. doi: 10.1016/j.ejvs.2013.04.021. [DOI] [PubMed] [Google Scholar]
- 14.Kilic A., Arnaoutakis D.J., Reifsnyder T., Black J.H., Abularrage C.J., Perler B.A. Management of infected vascular grafts. Vasc Med. 2016;21:53–60. doi: 10.1177/1358863X15612574. [DOI] [PubMed] [Google Scholar]
- 15.Berger P., Moll F.L. Aortic graft infections: is there still a role for axillobifemoral reconstruction? Semin Vasc Surg. 2011;24:205–210. doi: 10.1053/j.semvascsurg.2011.10.011. [DOI] [PubMed] [Google Scholar]
- 16.Batt M., Feugier P., Camou F., Coffy A., Senneville E., Caillon J. A meta-analysis of outcomes after in situ reconstructions for aortic graft infection. Angiology. 2018;69:370–379. doi: 10.1177/0003319717710114. [DOI] [PubMed] [Google Scholar]
- 17.Clagett G.P., Bowers B.L., Lopez-Viego M.A., Rossi M.B., Valentine R.J., Myers S.I. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg. 1993;218:239–248. doi: 10.1097/00000658-199309000-00003. discussion 248-249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ali A.T., Modrall J.G., Hocking J., Valentine R.J., Spencer H., Eidt J.F. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts. J Vasc Surg. 2009;50:30–39. doi: 10.1016/j.jvs.2009.01.008. [DOI] [PubMed] [Google Scholar]
